Only 6 matching reports were clearly identified as United States-based, so broader patient experiences were included and are labeled as additional context. PulseGLP analyzed 90 relevance-ranked patient reports across GLP-1, Ozempic, Semaglutide from r/GLP1, r/Ozempic, r/Semaglutide. The strongest structured pattern in this sample is symptom: Other, appearing in 10 extracted reports. The matching posts skew Risk-Alert, Neutral-Low, Analytical. This is a matched-sample finding, not a population-wide prevalence estimate.
Share of structured matched reports; this is not a population prevalence estimate.
"Search ProRX recall. I remember another company posting and being all open about it and what they were going to do if any of their members had those lots. Orderly was silent."
Patient · Semaglutide · r/Semaglutide · United States
"GLP-1's are Associated with Menstrual Cycle Changes My co-authors and I just published a study on menstrual side effects in women taking GLP-1 medications in Obstetrics & Gynecology , the official journal of the American College of Obstetricians and…"
Patient · GLP-1 · r/GLP1 · United States
"Devastated So I have been on Zepbound for a year and lost a significant amount of weight but about a month ago it needed a prior authorization and my medicaid denied it because it says im now in a regular BMI."
Patient · GLP-1 · r/GLP1 · United States
"This is because Reta isn’t yet FDA approved so most taking it aren’t obese nor are the studies out there yet. It doesn’t suggest Reta is different. Reta is more powerful so tends to have more effects."
Patient · Retatrutide · r/Retatrutide · United States
Sourced from GLP-1 patient communities · See community discussion →
Published: · Updated: